Rotavirus Gastroenteritis
Conditions
Keywords
prevention, rotavirus vaccine, gastroenteritis, systematic vaccination, infants, aged 6 to 12 weeks
Brief summary
Universal rotavirus vaccination program for infants born in Brest after February 2007, applied by the Centers for Maternal and Infant Health Protection, pediatricians and general practitioners. Prospective surveillance of hospitalizations for gastroenteritis within the Pediatric Units of Brest University Hospital with systematic testing for Rotavirus. Evaluation of the impact of the vaccination program on rotaviral gastroenteritis hospitalizations from 2007-2008 and 2008-2009, by comparison with epidemiological data from 2002-2007 in the absence of vaccination. The principal judgement criterion is the number of pediatric hospitalizations for rotaviral GEA during the 2008-2009 epidemic in children A) under the age of 2 and B) residing in the suburbs of Brest.
Interventions
BIOLOGICALRotateq vaccine
Vaccination against rotavirus Three oral doses (2 mL) between 6 to 26 weeks of life with at least 4 weeks between each dose.
Sponsors
MCM Vaccines B.V.
University Hospital, Brest
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
6 Weeks to 12 Weeks
Healthy volunteers
No
Inclusion criteria
* infants aged 6 to 12 weeks * born in Brest District, France * born between Feb 01, 2007 and Nov 19, 2009
Exclusion criteria
* contraindication to rotavirus vaccine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospitalization for gastroenteritis | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Emergency department consultation for gastroenteritis | 2 years |
Countries
France
Outcome results
None listed